Regional Health Financials
This page shows Regional Health (RHEPA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025's profit rebound looks driven more by non-operating cash sources and deleveraging than by core cash generation.
After two years when losses still converted into cash, FY2025 flipped to positive net income of$3.4M but operating cash flow of-$2.3M . Because investing cash flow added$15.1M while financing used$10.3M , the stronger cash balance reflects balance-sheet reshaping more than cash earned by the core business, which matters for a company still carrying meaningful debt.
The income statement shows a business with very high reported gross economics but limited operating room: an
The balance sheet is becoming less debt-heavy in one dimension but not more forgiving in another. Long-term debt has fallen to
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Regional Health's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Regional Health has an operating margin of 3.1%, meaning the company retains $3 of operating profit per $100 of revenue. This below-average margin results in a low score of 24/100, suggesting thin profitability after operating expenses. This is up from 0.9% the prior year.
Regional Health's revenue surged 189.9% year-over-year to $53.2M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
Regional Health has elevated debt relative to equity (D/E of 99.54), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.
Regional Health's current ratio of 0.67 is below the typical benchmark, resulting in a score of 8/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While Regional Health generated -$2.3M in operating cash flow, capex of $869K consumed most of it, leaving -$3.1M in free cash flow. This results in a low score of 31/100, reflecting heavy capital investment rather than weak cash generation.
Regional Health earns a strong 965.6% return on equity (ROE), meaning it generates $966 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100.
Regional Health passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Regional Health generates $-0.67 in operating cash flow (-$2.3M OCF vs $3.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Regional Health earns $0.6 in operating income for every $1 of interest expense ($1.7M vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Regional Health generated $53.2M in revenue in fiscal year 2025. This represents an increase of 189.9% from the prior year.
Regional Health's EBITDA was $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 67.7% from the prior year.
Regional Health reported $3.4M in net income in fiscal year 2025. This represents an increase of 204.7% from the prior year.
Regional Health earned $1.09 per diluted share (EPS) in fiscal year 2025. This represents an increase of 163.0% from the prior year.
Cash & Balance Sheet
Regional Health generated -$3.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 321.4% from the prior year.
Regional Health held $3.0M in cash against $34.7M in long-term debt as of fiscal year 2025.
Regional Health had 4M shares outstanding in fiscal year 2025. This represents an increase of 109.4% from the prior year.
Margins & Returns
Regional Health's gross margin was 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.
Regional Health's operating margin was 3.1% in fiscal year 2025, reflecting core business profitability. This is up 2.3 percentage points from the prior year.
Regional Health's net profit margin was 6.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 23.9 percentage points from the prior year.
Regional Health's ROE was 965.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Regional Health invested $869K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 64.0% from the prior year.
RHEPA Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.8M+37.2% | $15.1M+50.5% | $10.1M+39.9% | $7.2M+27.1% | $5.7M+33.9% | $4.2M-2.3% | $4.3M+4.8% | $4.1M |
| Cost of Revenue | N/A | $2.5M | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $12.7M | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $3.7M-1.2% | $3.7M+52.9% | $2.4M+8.9% | $2.2M+68.6% | $1.3M+8.1% | $1.2M-0.4% | $1.2M-24.7% | $1.6M |
| Operating Income | $3.1M+619.2% | -$594K-16.9% | -$508K-59.7% | -$318K-158.8% | $541K+280.3% | -$300K-240.2% | $214K+172.8% | -$294K |
| Interest Expense | $652K-13.2% | $751K+22.1% | $615K-5.8% | $653K-5.4% | $690K+1.9% | $677K+1.2% | $669K-0.7% | $674K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $2.7M-20.2% | $3.4M+333.4% | -$1.4M-14.8% | -$1.3M-122.2% | -$568K+42.2% | -$982K-39.1% | -$706K+26.6% | -$962K |
| EPS (Diluted) | N/A | $1.17+272.1% | $-0.68+27.7% | $-0.94 | N/A | $-0.52-36.8% | $-0.38+26.9% | $-0.52 |
RHEPA Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $67.8M-6.0% | $72.2M+20.0% | $60.1M+1.4% | $59.3M-2.0% | $60.5M+0.7% | $60.1M-2.1% | $61.3M+0.2% | $61.2M |
| Current Assets | $16.3M | N/A | N/A | N/A | $6.8M | N/A | N/A | N/A |
| Cash & Equivalents | $3.0M+200.0% | $1.0M+150.0% | $400K-20.0% | $500K-14.1% | $582K+16.4% | $500K-28.6% | $700K-12.5% | $800K |
| Inventory | $1.4M-5.6% | $1.4M | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $8.0M+4.0% | $7.7M+76.7% | $4.4M+20.0% | $3.6M+8.3% | $3.4M+65.3% | $2.0M+11.9% | $1.8M+24.1% | $1.5M |
| Goodwill | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M |
| Total Liabilities | $62.8M-9.0% | $69.0M+5.2% | $65.6M+3.4% | $63.4M+0.1% | $63.4M+1.5% | $62.4M-0.5% | $62.7M+1.3% | $62.0M |
| Current Liabilities | $24.2M | N/A | N/A | N/A | $20.4M | N/A | N/A | N/A |
| Long-Term Debt | $34.7M-28.5% | $48.6M-0.7% | $48.9M-0.5% | $49.2M+25.1% | $39.3M-20.9% | $49.7M-1.2% | $50.2M+0.5% | $50.0M |
| Total Equity | $349K+122.7% | -$1.5M+71.8% | -$5.5M-31.1% | -$4.2M-42.5% | -$2.9M-22.6% | -$2.4M-68.0% | -$1.4M-93.1% | -$734K |
| Retained Earnings | -$81.8M+3.5% | -$84.8M+4.1% | -$88.4M-1.7% | -$87.0M-2.2% | -$85.1M-0.7% | -$84.6M-1.2% | -$83.6M-0.9% | -$82.9M |
RHEPA Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.3M+29.6% | -$1.8M-416.2% | $569K+141.1% | $236K-75.2% | $953K+950.9% | -$112K-122.2% | $505K-15.4% | $597K |
| Capital Expenditures | $226K-20.1% | $283K-4.1% | $295K+353.8% | $65K-35.0% | $100K+185.7% | $35K-89.7% | $340K+518.2% | $55K |
| Free Cash Flow | -$1.5M+28.3% | -$2.1M-859.9% | $274K+60.2% | $171K-80.0% | $853K+680.3% | -$147K-189.1% | $165K-69.6% | $542K |
| Investing Cash Flow | $9.8M+71.6% | $5.7M+2029.5% | -$295K-353.8% | -$65K+35.0% | -$100K-185.7% | -$35K+89.7% | -$340K-518.2% | -$55K |
| Financing Cash Flow | -$6.4M-106.8% | -$3.1M-2470.2% | -$121K+79.4% | -$587K+33.5% | -$883K-1277.3% | $75K+113.3% | -$566K+24.6% | -$751K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
RHEPA Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 83.7% | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 14.8%+18.8pp | -3.9%+1.1pp | -5.1%-0.6pp | -4.4%-14.0pp | 9.6%+16.7pp | -7.1%-12.0pp | 5.0%+12.1pp | -7.1% |
| Net Margin | 13.0%-9.3pp | 22.3%+36.8pp | -14.4%+3.1pp | -17.5%-7.5pp | -10.0%+13.2pp | -23.2%-6.9pp | -16.3%+7.0pp | -23.3% |
| Return on Equity | 773.4% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 4.0%-0.7pp | 4.7%+7.1pp | -2.4%-0.3pp | -2.1%-1.2pp | -0.9%+0.7pp | -1.6%-0.5pp | -1.1%+0.4pp | -1.6% |
| Current Ratio | 0.67 | N/A | N/A | N/A | 0.33 | N/A | N/A | N/A |
| Debt-to-Equity | 99.54+131.1 | -31.59-22.6 | -8.97+2.9 | -11.82+1.6 | -13.46+7.4 | -20.86+14.6 | -35.46+32.7 | -68.13 |
| FCF Margin | -7.2%+6.6pp | -13.8%-16.5pp | 2.7%+0.3pp | 2.4%-12.7pp | 15.1%+18.6pp | -3.5%-7.3pp | 3.8%-9.3pp | 13.1% |
Note: The current ratio is below 1.0 (0.67), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Regional Health's annual revenue?
Regional Health (RHEPA) reported $53.2M in total revenue for fiscal year 2025. This represents a 189.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Regional Health's revenue growing?
Regional Health (RHEPA) revenue grew by 189.9% year-over-year, from $18.3M to $53.2M in fiscal year 2025.
Is Regional Health profitable?
Yes, Regional Health (RHEPA) reported a net income of $3.4M in fiscal year 2025, with a net profit margin of 6.3%.
What is Regional Health's EBITDA?
Regional Health (RHEPA) had EBITDA of $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Regional Health have?
As of fiscal year 2025, Regional Health (RHEPA) had $3.0M in cash and equivalents against $34.7M in long-term debt.
What is Regional Health's gross margin?
Regional Health (RHEPA) had a gross margin of 86.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Regional Health's operating margin?
Regional Health (RHEPA) had an operating margin of 3.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Regional Health's net profit margin?
Regional Health (RHEPA) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Regional Health's return on equity (ROE)?
Regional Health (RHEPA) has a return on equity of 965.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Regional Health's free cash flow?
Regional Health (RHEPA) generated -$3.1M in free cash flow during fiscal year 2025. This represents a -321.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Regional Health's operating cash flow?
Regional Health (RHEPA) generated -$2.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Regional Health's total assets?
Regional Health (RHEPA) had $67.8M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Regional Health's capital expenditures?
Regional Health (RHEPA) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Regional Health's current ratio?
Regional Health (RHEPA) had a current ratio of 0.67 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Regional Health's debt-to-equity ratio?
Regional Health (RHEPA) had a debt-to-equity ratio of 99.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Regional Health's return on assets (ROA)?
Regional Health (RHEPA) had a return on assets of 5.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Regional Health's cash runway?
Based on fiscal year 2025 data, Regional Health (RHEPA) had $3.0M in cash against an annual operating cash burn of $2.3M. This gives an estimated cash runway of approximately 16 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Regional Health's Piotroski F-Score?
Regional Health (RHEPA) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Regional Health's earnings high quality?
Regional Health (RHEPA) has an earnings quality ratio of -0.67x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Regional Health cover its interest payments?
Regional Health (RHEPA) has an interest coverage ratio of 0.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Regional Health?
Regional Health (RHEPA) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.